Search
Flurocitabine
go.drugbank.com/drugs/DB20317ExperimentalThe usage of the INN stem '-citabine' in the name indicates that Flurocitabine is a nucleoside antiviral or antineoplastic agent, cytarabine or azacitidine derivative.
Acloproxalap
go.drugbank.com/drugs/DB21553InvestigationalAcloproxalap is under investigation in clinical trial NCT06685692 (A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)).
Alefacept
go.drugbank.com/drugs/DB00092ApprovedWithdrawnImmunosuppressive dimeric fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 (LFA-3) linked to the Fc (hinge, CH2 and CH3 domains) portion of human IgG1. Produced by CHO cells,...
Picoplatin
go.drugbank.com/drugs/DB04874InvestigationalPicoplatin is a cytotoxic platinum compound in clinical development for the treatment of patients with solid tumors.
TT 173
go.drugbank.com/drugs/DB17717InvestigationalTT 173 is a Modified Human Tissue Factor currently being investigated to treat bleeding disorders such as hemophilia and von Willebrand disease, as well as bleeding episodes in cutaneous injuries or dental
Fuzapladib
go.drugbank.com/drugs/DB19478ExperimentalThe usage of the INN stem '-pladib' in the name indicates that Fuzapladib is a phospholipase A2 inhibitor. Fuzapladib has a monoisotopic molecular weight of 379.12 Da.
Ponalrestat
go.drugbank.com/drugs/DB19717ExperimentalThe usage of the INN stem '-restat' in the name indicates that Ponalrestat is a aldose reductase inhibitor. Ponalrestat has a monoisotopic molecular weight of 390.0 Da.
Vatinoxan
go.drugbank.com/drugs/DB19781ExperimentalThe usage of the INN stem '-oxan(e)' in the name indicates that Vatinoxan is a benzodioxane derivative. Vatinoxan has a monoisotopic molecular weight of 418.17 Da.
Flesinoxan
go.drugbank.com/drugs/DB19853ExperimentalThe usage of the INN stem '-oxan(e)' in the name indicates that Flesinoxan is a benzodioxane derivative. Flesinoxan has a monoisotopic molecular weight of 415.19 Da.
Solimastat
go.drugbank.com/drugs/DB19872ExperimentalThe usage of the INN stem '-mastat' in the name indicates that Solimastat is a matrix metalloproteinase inhibitor. Solimastat has a monoisotopic molecular weight of 408.24 Da.